Piper Sandler Reiterates Overweight on Tandem Diabetes Care (TNDM) After Analyzing Pump Shipment Data
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $132.00 price target on Tandem Diabetes Care (NASDAQ: TNDM) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
